Adon Health has built a health platform that offers laboratory tests, doctor consultations, medication delivery, and therapy management with a focus on testosterone replacement therapies for men. It aims to enable patients to manage their care digitally and in one place, making it significantly less complex and time-consuming than the current standard. The startup does not want to limit itself to testosterone replacement therapies. In the future, Adon Health plans to offer additional digital health services and preventive medicine for men.
The startup was founded in late 2023 by two former McKinsey colleagues, Maximilian Schubert and Dr. med. Jonathan Apasu. After completing a beta testing phase, the platform has already launched and is supporting first patients in the German market. The startup has now successfully completed its first funding round, raising an undisclosed six-figure amount. Swiss VC fund Backbone Ventures is leading the pre-seed round. Additionally, Vera Baker from the Atomico Angel Programme and several business angels with experience in building companies in the European health and B2C ecosystem are participating.
Maximilian Schubert, co-founder of Adon Health, explains:
“We have an opportunity to provide millions of patients with better and more modern healthcare that meets the technological standards of the 21st century. We want to enable patients to use a platform that makes the care experience as modern and user-centric as operating an iPhone. More importantly, we want to play a central role in raising awareness across Europe about major, underserved health problems like testosterone deficiency, and to help people not just reactively but also preventively.”
Adon Health wants to “shape how millions of people in Europe receive medical care”
Co-founder and physician Jonathan Apasu adds:
“During our interactions with patients, we observed the serious problems that complex care processes can cause for those affected. We want to help shape how millions of people in Europe receive medical care. The opportunities that technology has created in recent decades are abundant. We want to make them accessible to patients while maintaining the highest medical standards and collaborating with all parts of the conventional healthcare ecosystem. Applying such a model to testosterone deficiency is just the beginning. Particularly in more complicated care processes, there has been a lack of patient-centered digital innovation in recent years. We are confident that there are significant benefits to be gained for healthcare in Europe.”
Jan Claudio Muñoz, partner at Backbone Ventures, is convinced of Adon Health’s potential:
“We see great potential in simplifying complex and underserved care processes with a vertically integrated health platform. The healthcare ecosystem has changed – with important regulatory changes in telemedicine and record usage rates of online services, a new era for digital solutions is dawning. We have the opportunity to create significant added value for patients through technological innovation. In particular, in the European region, care in men’s health has barely evolved, despite the clear need for new solutions that address the deficient health standards of men.”
